Waltham, MA, September 6, 2022 — Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Maia Germain as Chief People Officer (CPO) and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s CFO and Head of Corporate Operations.
Ms. Germain has a proven track record for leading high-growth companies through transformation and building positive employee cultures that serve the overall business. She joins Trinity after holding Senior Vice President roles…
Read Now
The Listing is a Second Year Honor for the Company
Waltham, MA, August 17, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it was named to the 2022 Inc. 5000 fastest-growing private companies list. This is the second year in a row Trinity has been included on the prestigious list. The Inc. 5000 list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment – its independent businesses.
“Our…
Read Now
The partnership pairs Bain’s extensive experience across the global life sciences value chain with Trinity’s specialized, evidence-based solutions for life sciences companies
BOSTON, Aug. 8, 2022 /PRNewswire/ — Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions, have announced a strategic partnership to bring together Bain’s extensive global experience across the life sciences value chain with Trinity’s deep technical expertise in biopharma and medtech. The partnership includes Bain & Company taking a minority investment…
Read Now
Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals
Waltham, MA, August 4, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by…
Read Now
Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio
Waltham, MA, July 19, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more…
Read Now
Commerical Teams in the Life Sciences Need a Gradual, Stepwise Approach to Product Launches to Achieve Success, according to a New White Paper Available Now from Trinity Life Sciences
Waltham, MA, June 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that 62 percent of biopharma products that launched between September 2019 and December 2021 underperformed expectations, including 24 out of 28 non-rare, non-oncology products. According to a new white paper entitled Empowering the…
Read Now
Webinar Entitled “Reimagining Work Models in the Life Sciences: Implications for the Future of Work” Will be Held on June 23
Waltham, MA, June 21, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work. The study is the first of its kind for the life sciences industry as it provides objective data to help companies make informed…
Read Now
“Patient Centricity: Optimizing Integration throughout the Lifecycle” Available Now from Trinity Life Sciences
Waltham, MA, June 13, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out the complexities life sciences companies are grappling with as they pull the “idea” of patient centricity through to execution and measurable results. While the vision and goal of patient centricity are clear, the challenge is crafting concrete steps to integrate the patient voice throughout the product lifecycle and…
Read Now
Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a System In-House
Waltham, MA, June 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the launch of Government Pricing (GP) services within TGaS Advisors. The new services help pre-commercial and emerging life sciences companies develop their GP policies and methodologies and provide support for ongoing GP calculations. Because drug pricing in the U.S. remains at…
Read Now
Office Relocation in Gurgaon Creates Space for Growth and Innovation in the Asia-Pacific Region
Gurgaon, India, May 16, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the opening of its next-generation office space in Gurgaon, India. The opening of the new office is part of Trinity’s ongoing commitment to support development and innovation in the Asia-Pacific region.
Located near the “cyber hub of India,” the impressive new office boasts sleek contemporary design and state-of-the-art…
Read Now
